AXIS Continues Clinical Research During COVID-19 Restrictions

Dilworth, MN – Clinical and bioanalytical studies supporting pharmacology projects and multi-site patient trials continue at AXIS. Various projects supporting research to address the Coronavirus pandemic and other critical research for oncology, neurology, women’s health, and other key therapeutic areas are ongoing.

We have placed critical polices for safety and sanitization protocols for staff and participants. Daily reviews are being undertaken to ensure that our facilities and overall operations continue to be a clean and safe environment for all. We believe these steps will be appropriate and allow healthy volunteer studies with in-house stays to be conducted safely as well as overseeing clinical trials given the current SARS-Cov2 outbreak restrictions.

More News

Clinical Partnership Announcement

AXIS Clinicals LLC and Joanneum Research Forschungsgesellschaft mbH are excited to announce the first ever partnership for the clinical applications of dermal open flow microperfusion

Read more >

Interested in bringing your study to AXIS? Please reach out:

John Pottier
Senior VP Business Development